Annual Current Liabilities
$53.72 M
+$519.00 K+0.98%
December 31, 2023
Summary
- As of February 8, 2025, TGTX annual total current liabilities is $53.72 million, with the most recent change of +$519.00 thousand (+0.98%) on December 31, 2023.
- During the last 3 years, TGTX annual current liabilities has fallen by -$33.83 million (-38.64%).
- TGTX annual current liabilities is now -38.64% below its all-time high of $87.55 million, reached on December 31, 2020.
Performance
TGTX Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$125.11 M
+$16.45 M+15.14%
September 30, 2024
Summary
- As of February 8, 2025, TGTX quarterly total current liabilities is $125.11 million, with the most recent change of +$16.45 million (+15.14%) on September 30, 2024.
- Over the past year, TGTX quarterly current liabilities has increased by +$25.43 million (+25.51%).
- TGTX quarterly current liabilities is now at all-time high.
Performance
TGTX Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
TGTX Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +1.0% | +25.5% |
| 3 y3 years | -38.6% | +72.2% |
| 5 y5 years | +38.3% | +72.2% |
TGTX Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -17.8% | +1.0% | at high | +243.3% |
| 5 y | 5-year | -38.6% | +1.0% | at high | +243.3% |
| alltime | all time | -38.6% | >+9999.0% | at high | >+9999.0% |
TG Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $125.11 M(+15.1%) |
| Jun 2024 | - | $108.66 M(+9.0%) |
| Mar 2024 | - | $99.68 M(+85.6%) |
| Dec 2023 | $53.72 M(+1.0%) | $53.72 M(-6.9%) |
| Sep 2023 | - | $57.68 M(-20.6%) |
| Jun 2023 | - | $72.67 M(+15.2%) |
| Mar 2023 | - | $63.08 M(+18.6%) |
| Dec 2022 | $53.20 M(-18.6%) | $53.20 M(+46.0%) |
| Sep 2022 | - | $36.45 M(-15.9%) |
| Jun 2022 | - | $43.33 M(-20.7%) |
| Mar 2022 | - | $54.66 M(-16.4%) |
| Dec 2021 | $65.38 M(-25.3%) | $65.38 M(-25.4%) |
| Sep 2021 | - | $87.66 M(+0.1%) |
| Jun 2021 | - | $87.55 M(-5.3%) |
| Mar 2021 | - | $92.49 M(+5.6%) |
| Dec 2020 | $87.55 M(+3.7%) | $87.55 M(+12.7%) |
| Sep 2020 | - | $77.67 M(+15.0%) |
| Jun 2020 | - | $67.54 M(+7.0%) |
| Mar 2020 | - | $63.12 M(-25.3%) |
| Dec 2019 | $84.45 M(+117.3%) | $84.45 M(+5.3%) |
| Sep 2019 | - | $80.20 M(+43.3%) |
| Jun 2019 | - | $55.97 M(-8.2%) |
| Mar 2019 | - | $60.94 M(+56.8%) |
| Dec 2018 | $38.85 M(+39.0%) | $38.85 M(-3.4%) |
| Sep 2018 | - | $40.24 M(+8.9%) |
| Jun 2018 | - | $36.94 M(+10.8%) |
| Mar 2018 | - | $33.34 M(+19.3%) |
| Dec 2017 | $27.96 M(+65.6%) | $27.96 M(+41.3%) |
| Sep 2017 | - | $19.79 M(-4.7%) |
| Jun 2017 | - | $20.76 M(+5.2%) |
| Mar 2017 | - | $19.73 M(+16.9%) |
| Dec 2016 | $16.88 M(+60.3%) | $16.88 M(-0.0%) |
| Sep 2016 | - | $16.88 M(+19.6%) |
| Jun 2016 | - | $14.12 M(+58.8%) |
| Mar 2016 | - | $8.89 M(-15.5%) |
| Dec 2015 | $10.53 M(+105.6%) | $10.53 M(+8.7%) |
| Sep 2015 | - | $9.69 M(+5.2%) |
| Jun 2015 | - | $9.21 M(-3.6%) |
| Mar 2015 | - | $9.55 M(+86.5%) |
| Dec 2014 | $5.12 M(-18.9%) | $5.12 M(-42.5%) |
| Sep 2014 | - | $8.90 M(+241.5%) |
| Jun 2014 | - | $2.61 M(+31.1%) |
| Mar 2014 | - | $1.99 M(-68.5%) |
| Dec 2013 | $6.32 M(+185.1%) | $6.32 M(+11.3%) |
| Sep 2013 | - | $5.68 M(+63.8%) |
| Jun 2013 | - | $3.47 M(+40.2%) |
| Mar 2013 | - | $2.47 M(+11.6%) |
| Dec 2012 | $2.22 M(+38.0%) | $2.22 M(-25.1%) |
| Sep 2012 | - | $2.96 M(+25.9%) |
| Jun 2012 | - | $2.35 M(+92.2%) |
| Mar 2012 | - | $1.22 M(-23.9%) |
| Dec 2011 | $1.61 M(-51.2%) | $1.61 M(+6.0%) |
| Sep 2011 | - | $1.52 M(-59.9%) |
| Jun 2011 | - | $3.78 M(+12.9%) |
| Mar 2011 | - | $3.35 M(+1.8%) |
| Dec 2010 | $3.29 M | $3.29 M(-21.7%) |
| Sep 2010 | - | $4.21 M(-14.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2010 | - | $4.93 M(-31.6%) |
| Mar 2010 | - | $7.20 M(+184.5%) |
| Dec 2009 | $2.53 M(+70.4%) | $2.53 M(+58.4%) |
| Sep 2009 | - | $1.60 M(-11.1%) |
| Jun 2009 | - | $1.80 M(+81.0%) |
| Mar 2009 | - | $993.10 K(-33.2%) |
| Dec 2008 | $1.49 M(-20.6%) | $1.49 M(-26.2%) |
| Sep 2008 | - | $2.01 M(+37.3%) |
| Jun 2008 | - | $1.47 M(-17.9%) |
| Mar 2008 | - | $1.79 M(-4.6%) |
| Dec 2007 | $1.87 M(-3.7%) | $1.87 M(+4.5%) |
| Sep 2007 | - | $1.79 M(-29.2%) |
| Jun 2007 | - | $2.53 M(+15.4%) |
| Mar 2007 | - | $2.19 M(+12.8%) |
| Dec 2006 | $1.94 M(+16.7%) | $1.94 M(+37.4%) |
| Sep 2006 | - | $1.41 M(-36.1%) |
| Jun 2006 | - | $2.21 M(-1.4%) |
| Mar 2006 | - | $2.25 M(+34.9%) |
| Dec 2005 | $1.67 M(+39.3%) | $1.67 M(-7.9%) |
| Sep 2005 | - | $1.81 M(+24.7%) |
| Jun 2005 | - | $1.45 M(+14.2%) |
| Mar 2005 | - | $1.27 M(+6.3%) |
| Dec 2004 | $1.20 M(+23.8%) | $1.20 M(-18.9%) |
| Sep 2004 | - | $1.47 M(+136.2%) |
| Jun 2004 | - | $624.40 K(-17.6%) |
| Mar 2004 | - | $757.80 K(-21.6%) |
| Dec 2003 | $966.00 K(-10.8%) | $966.00 K(-23.7%) |
| Sep 2003 | - | $1.27 M(+20.0%) |
| Jun 2003 | - | $1.05 M(-0.8%) |
| Mar 2003 | - | $1.06 M(-1.8%) |
| Dec 2002 | $1.08 M(+113.0%) | $1.08 M(+115.0%) |
| Sep 2002 | - | $503.90 K(+17.8%) |
| Jun 2002 | - | $427.70 K(-11.8%) |
| Mar 2002 | - | $484.70 K(-4.7%) |
| Dec 2001 | $508.60 K(-75.6%) | $508.60 K(-32.0%) |
| Sep 2001 | - | $748.40 K(+5.9%) |
| Jun 2001 | - | $706.90 K(-9.3%) |
| Mar 2001 | - | $779.20 K(-62.5%) |
| Dec 2000 | $2.08 M(+316.1%) | $2.08 M(+95.9%) |
| Sep 2000 | - | $1.06 M(+95.7%) |
| Jun 2000 | - | $542.50 K(+9.4%) |
| Mar 2000 | - | $495.90 K(-0.8%) |
| Dec 1999 | $500.00 K(-28.6%) | $500.00 K(+150.0%) |
| Sep 1999 | - | $200.00 K(-50.0%) |
| Jun 1999 | - | $400.00 K(-33.3%) |
| Mar 1999 | - | $600.00 K(-14.3%) |
| Dec 1998 | $700.00 K(+75.0%) | $700.00 K(+16.7%) |
| Sep 1998 | - | $600.00 K(0.0%) |
| Jun 1998 | - | $600.00 K(+200.0%) |
| Mar 1998 | - | $200.00 K(-50.0%) |
| Dec 1997 | $400.00 K(+33.3%) | $400.00 K(+33.3%) |
| Sep 1997 | - | $300.00 K(-25.0%) |
| Jun 1997 | - | $400.00 K(+33.3%) |
| Mar 1997 | - | $300.00 K(0.0%) |
| Dec 1996 | $300.00 K | $300.00 K(0.0%) |
| Sep 1996 | - | $300.00 K(-25.0%) |
| Jun 1996 | - | $400.00 K |
FAQ
- What is TG Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for TG Therapeutics?
- What is TG Therapeutics annual current liabilities year-on-year change?
- What is TG Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for TG Therapeutics?
- What is TG Therapeutics quarterly current liabilities year-on-year change?
What is TG Therapeutics annual total current liabilities?
The current annual current liabilities of TGTX is $53.72 M
What is the all time high annual current liabilities for TG Therapeutics?
TG Therapeutics all-time high annual total current liabilities is $87.55 M
What is TG Therapeutics annual current liabilities year-on-year change?
Over the past year, TGTX annual total current liabilities has changed by +$519.00 K (+0.98%)
What is TG Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of TGTX is $125.11 M
What is the all time high quarterly current liabilities for TG Therapeutics?
TG Therapeutics all-time high quarterly total current liabilities is $125.11 M
What is TG Therapeutics quarterly current liabilities year-on-year change?
Over the past year, TGTX quarterly total current liabilities has changed by +$25.43 M (+25.51%)